18F-NOTA-FAPI-04 PET/CT metabolic parameters combined with hematological biomarkers predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-025-07506-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Yongbin Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Acade…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoadjuvant Therapy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Key Research and Development Program of Xinjiang Uygur Autonomous Region of China, Taishan Scholars Project of Shandong Province.
Abstract (Originalsprache)
OBJECTIVE: To investigate the predictive value of pretreatment 18F-NOTA-FAPI-04 PET/CT metabolic parameters combined with hematological biomarkers for pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: This retrospective study included 19 patients with locally advanced ESCC who underwent nCRT followed by surgery at Shandong Cancer Hospital from March 2022 to May 2023. Pretreatment clinical baseline data, 18F-NOTA-FAPI-04 PET/CT metabolic parameters, and hematological biomarkers were collected. Univariate and multivariate logistic regression analyses were used to select predictive parameters. A logistic regression model was constructed to predict pCR, and its performance was evaluated using receiver operating characteristic (ROC) curves, decision curves, and a nomogram. RESULTS: Among 19 patients, 11 achieved pCR, and 8 achieved non-pCR status. Univariate and multivariate analyses identified metabolic tumor volume (MTV) (OR = 0.978, p = 0.017) and platelet count (PLT) (OR = 1.003, p = 0.016) as independent predictors of pCR. By fitting a logistic regression model, the two-parameter joint model reached an AUC of 0.909, which was significantly better than the single indicator (MTV, AUC = 0.716; PLT, AUC = 0.761). The nomogram demonstrated that lower MTV (optimal threshold ≤ 27.47) and higher PLT (optimal threshold ≥ 330.5) values were associated with a higher likelihood of pCR. CONCLUSION: Pretreatment 18F-NOTA-FAPI-04 PET/CT-derived MTV combined with PLT can noninvasively predict pCR after nCRT in ESCC patients, providing a basis for personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440 Jiyan Road, Huaiyin District, Jinan, S…
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Förderung
- The Key Research and Development Program of Xinjiang Uygur Autonomous Region of China
- Taishan Scholars Project of Shandong Province
Zitieren
APA
Cui, Y., Wang, H., Wang, N., Yao, Z., Li, Z., Wu, Q., & Yin, Y. (2026). 18F-NOTA-FAPI-04 PET/CT metabolic parameters combined with hematological biomarkers predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07506-6
Vancouver
Cui Y, Wang H, Wang N, Yao Z, Li Z, Wu Q, et al. 18F-NOTA-FAPI-04 PET/CT metabolic parameters combined with hematological biomarkers predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07506-6
BibTeX
@article{Cui2026,
author = {Cui, Yongbin and Wang, Huadong and Wang, Nan and Yao, Zhijie and Li, Zhenjiang and Wu, Qiang and Yin, Yong},
title = {18F-NOTA-FAPI-04 PET/CT metabolic parameters combined with hematological biomarkers predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-025-07506-6}
}
EUVIMED